Intellia Therapeutics (NTLA) Non-Current Assets (2015 - 2026)
Intellia Therapeutics' Non-Current Assets came in at $329.33 million for Q2 2026, down 18.3% from $402.95 million a year earlier but up 12.7% from the prior quarter.
Powered by 
Analysis
Intellia Therapeutics (NTLA) Non-Current Assets (2015 - 2026) Analysis & Trends
At the end of FY2025, Intellia Therapeutics' Non-Current Assets was $314.42 million, down 43.0% from FY2024.
- Non-Current Assets carries a five-year compound annual growth rate of 39.4% (FY2020 to FY2025).
- Going back by year, Non-Current Assets was $551.15 million in FY2024 (+82.1%), $302.65 million in FY2023 (-0.2%), $303.32 million in FY2022 (-42.2%) and $525.16 million in FY2021 (+778.1%).
- The five-year range for quarterly Non-Current Assets is $214.99 million (Q2 2022) to $551.15 million (Q4 2024).
- Year-over-year, Non-Current Assets has declined for five consecutive quarters, with growth averaging 0.4% over the last eight quarters.
- The fastest year-over-year change in Non-Current Assets over five years came in Q4 2021 (growth of 778.1%), and the weakest in Q3 2022 (a decline of 56.6%).
- Business Quant data shows NTLA's Non-Current Assets at $292.33 million (Q1 2026), $314.42 million (Q4 2025) and $343.33 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 141.29 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 101.45 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 125.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 94.68 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 87.87 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 60.68 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 35.42 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 159.77 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 14.88 Bn |
| 10 | Intellia Therapeutics | 1.60 Bn | 1.60 Bn | - | 329.33 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 329.33 Mn |
| Mar 31, 2026 | 292.33 Mn |
| Dec 31, 2025 | 314.42 Mn |
| Sep 30, 2025 | 343.33 Mn |
| Jun 30, 2025 | 402.95 Mn |
| Mar 31, 2025 | 434.77 Mn |
| Dec 31, 2024 | 551.15 Mn |
| Sep 30, 2024 | 462.45 Mn |
| Jun 30, 2024 | 434.33 Mn |
| Mar 31, 2024 | 375.55 Mn |
| Dec 31, 2023 | 302.65 Mn |
| Sep 30, 2023 | 349.86 Mn |
| Jun 30, 2023 | 383.63 Mn |
| Mar 31, 2023 | 454.22 Mn |
| Dec 31, 2022 | 303.32 Mn |
| Sep 30, 2022 | 225.51 Mn |
| Jun 30, 2022 | 214.99 Mn |
| Mar 31, 2022 | 327.42 Mn |
| Dec 31, 2021 | 525.16 Mn |
| Sep 30, 2021 | 520.19 Mn |
API Access
Intellia Therapeutics Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-assets&ticker=NTLA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-assets", "ticker": "NTLA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-assets&ticker=NTLA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();